Sex‐specific immune cell signatures define clinical stages and severity of Alzheimer's disease

Abstract

Background: Immune‐related changes impact clinical outcomes in people with Alzheimer's disease (AD). However, these changes have yet to translate into robust blood biomarkers of AD, in part due to high inter‐individual variation, small effect sizes, and the indirect relationship between peripheral blood and central nervous system changes.

The paper